Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BTP-114 |
Synonyms | |
Therapy Description |
BTP-114 is a prodrug of cisplatin that has prolonged plasma circulation time and increased tumor distribution, which leads to improved anti-tumor activity (Cancer Res 2015;75(15 Suppl):Abstract nr 4484). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BTP-114 | BTP 114 | BTP-114 is a prodrug of cisplatin that has prolonged plasma circulation time and increased tumor distribution, which leads to improved anti-tumor activity (Cancer Res 2015;75(15 Suppl):Abstract nr 4484). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02950064 | Phase I | BTP-114 | A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations | Unknown status | USA | 0 |